[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.121.230. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
US Preventive Services Task Force
Recommendation Statement
February 25, 2020

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force
JAMA. 2020;323(8):757-763. doi:10.1001/jama.2020.0435
Abstract

Importance  Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person’s independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individuals in the United States, and its prevalence increases with age.

Objective  To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a review of the evidence on screening for cognitive impairment, including mild cognitive impairment and mild to moderate dementia, in community-dwelling adults, including those 65 years or older residing in independent living facilities.

Population  This recommendation applies to community-dwelling older adults 65 years or older, without recognized signs or symptoms of cognitive impairment.

Evidence Assessment  The USPSTF concludes that the evidence is lacking, and the balance of benefits and harms of screening for cognitive impairment cannot be determined.

Recommendation  The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults. (I statement)

×